A next-generation molecular diagnostic tool developed using PlexBio's πCode technology for detecting SARS-CoV-2 variants. The assay is designed to address challenges in coronavirus detection and variant identification.
Manufactured by
Taipei City, Taiwan
About PlexBio PlexBio Co., Ltd., founded in 2010 and headquartered in Taiwan, is a leading developer and manufacturer of multiplex in vitro diagnostic (IVD) solutions tailored for precision medicine. At the core of PlexBio s innovation is the patented πCode® MicroDisc technology, enabling simultaneous detection of dozens to hundreds of genetic mutations or biomarkers in a single reaction. This forms the basis of the IntelliPlex® platform , supporting applications in oncology, infectious diseases, and immunoassays. To streamline laboratory workflows, PlexBio developed the IntelliPrep TRIO 240 —a fully automated sample preparation system that integrates nucleic acid extraction, quantification, normalization, and PCR assay setup. Supporting up to 24 samples per run, TRIO 240 reduces hands-on time and minimizes human error, while ensuring standardized sample prep for downstream applications such as qPCR, dPCR, NGS, or PlexBio's πCode-based detection. PlexBio is committed to improving diagnostic accuracy, reducing testing costs, and enhancing patient outcomes by delivering innovative, scalable, and cost-effective molecular testing solutions. With ISO 13485, GMP, CE-IVD, and FDA-listed products, PlexBio continues to expand globally through clinical collaborations, RUO/LDT applications, and distribution partnerships.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Innobiochips SAS
France · 2 relevant products
Intelligenome
United States · 1 relevant product
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd
China · 1 relevant product
Cambrian Bioworks LLC
United States · 1 relevant product
Grupo Stra - Saúde e Bem-Estar!
Brazil · 1 relevant product
Applied Biocode, Inc.
United States · 3 relevant products
ZiP Diagnostics
Australia · 1 relevant product
TrustBio Corporation
Taiwan · 1 relevant product
Bio-Techne Diagnostics
United States · 2 relevant products
Gulf Scientific Corporation
United Arab Emirates · 1 relevant product
35 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 57 closest product alternatives
Innobiochips SAS · France
An advanced COVID-19 diagnostic tool based on Innobiochips' proprietary high-resolution multiplex assay technology. CoViDiag represents the most advanced diagnostic solution for COVID-19 detection and is used for infectious disease diagnostics.
Intelligenome · United States
IntelliGenome's proprietary CRISPR technology platform for decentralized diagnostics. Accurately detects pathogens and monitors treatment response across multiple applications including TB and oncology.
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd · China
Molecular diagnostics platform for infectious disease identification and confirmation. Utilizes proprietary technology for rapid and accurate pathogen detection.
Cambrian Bioworks LLC · United States
Automated platform for molecular diagnostics of infectious pathogens. Integrates nucleic acid extraction and amplification for rapid disease identification.
Grupo Stra - Saúde e Bem-Estar! · Brazil
A point-of-care molecular biology platform designed for integrated laboratory testing. This system enables rapid molecular diagnostics in laboratory settings with automated analysis capabilities.
Applied Biocode, Inc. · United States
Molecular diagnostic assay for detection of SARS-CoV-2. FDA-cleared in vitro diagnostic test providing reliable identification of COVID-19 infection.
ZiP Diagnostics · Australia
IVD point-of-care diagnostic test for SARS-CoV-2 detection using LAMP-based nucleic acid amplification technology. TGA ARTG-listed for human health applications with no cold chain requirement.
TrustBio Corporation · Taiwan
Molecular diagnostic tools for oncology applications. Supports precision diagnostics for cancer-related molecular analysis.
Bio-Techne Diagnostics · United States
Molecular diagnostic assay platform delivering high sensitivity and specificity for hard-to-amplify genetic sequences using long-read sequencing. Designed for inherited genetics testing with consolidated workflows and reduced reflex testing requirements.
Gulf Scientific Corporation · United Arab Emirates
Advanced protein biomarker detection and analysis platform. Enables precision diagnostics for disease detection and patient stratification in clinical laboratories.
Hangzhou Allsheng Instruments Co., Ltd. · China
Point-of-care testing system for molecular detection applications. Enables rapid on-site diagnosis with molecular-level precision for clinical or field testing.
Innobiochips SAS · France
High-resolution multiplex COVID-19 diagnostic assay based on proprietary Siryus technology. Provides advanced detection capabilities for infectious disease diagnostics.
45 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products